Rapid Developability Assessments to Formulate Recombinant Protein Antigens as Stable, Low-Cost, Multi-Dose Vaccine Candidates: Case-Study With Non-Replicating Rotavirus (NRRV) Vaccine Antigens

A two-step developability assessment workflow is described to screen variants of recombinant protein antigens under various formulation conditions to rapidly identify stable, aluminum-adjuvanted, multi-dose vaccine candidates. For proof-of-concept, a series of sequence variants of the recombinant no...

Descripción completa

Detalles Bibliográficos
Autores principales: Sawant, Nishant, Kaur, Kawaljit, Holland, David A., Hickey, John M., Agarwal, Sanjeev, Brady, Joseph R., Dalvie, Neil C., Tracey, Mary Kate, Velez-Suberbie, M. Lourdes, Morris, Stephen A., Jacob, Shaleem I., Bracewell, Daniel G., Mukhopadhyay, Tarit K., Love, Kerry R., Love, J. Christopher, Joshi, Sangeeta B., Volkin, David B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884052/
https://www.ncbi.nlm.nih.gov/pubmed/33285182
http://dx.doi.org/10.1016/j.xphs.2020.11.039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884052/
https://www.ncbi.nlm.nih.gov/pubmed/33285182
http://dx.doi.org/10.1016/j.xphs.2020.11.039

Ejemplares similares